Illumina ILMN
$ 131.02
-0.5%
Quarterly report 2024-Q2
added 08-07-2024
Country |
USA |
IPO year |
2000 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBALSPB |
CEO |
Mr. Francis deSouza |
Employees in the company |
7 700 |
Shares |
158 M |
Market Cap[1] |
$ 20.7 B |
EBITDA (LTM) |
$ -1.69 B |
P/E (LTM) |
-8.22 |
P/S (LTM) |
4.3 |
EPS (LTM) |
-14.73 |
Other stocks of industry "Diagnostics research"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.